NanoDx
PrivateLast Round
Series C
Jul 1, 2020
Total Funding Raised
$27.95M
Momentum Score
25 /100
Company Overview
NanoDx is a medical device company that develops point-of-care products for the objective diagnosis and management of concussions and other traumatic brain injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Defense Tech, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoDx Comps
Public and private peers based on sector, stage, and business model.
NanoDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 1, 2020 | ||||
| Series B Extension | Apr 10, 2017 | ||||
| Series B | Feb 3, 2016 | ||||
| Series A | Aug 19, 2013 |
NanoDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paulson Investment Company | Series A |
| Provident Healthcare Capital | Series B Extension, Series B |
| MedScience Ventures | Series B Extension |
| Shepherd Kaplan Krochuk | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 63% MoM.
- Nov 13, 2025
Monthly visitors grew 142% MoM, reaching 1.1K.
NanoDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoDx's valuation, stock price, and market status.
